Filing Details

Accession Number:
0000899243-22-001527
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-10 20:37:57
Reporting Period:
2022-01-06
Accepted Time:
2022-01-10 20:37:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658551 Amylyx Pharmaceuticals Inc. AMLX Pharmaceutical Preparations (2834) 464600503
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727550 R. Paul Fonteyne C/O Amylyx Pharmaceuticals, Inc.
43 Thorndike Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-06 3,947 $19.00 3,947 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2022-01-06 8,400 $0.00 8,400 $19.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,400 2032-01-06 No 4 A Direct
Footnotes
  1. This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.